New fertility treatment approved in Europe
Submitted by Shelby D Burns Mon 02/01/2010 Beakers Merck announced in Europe the approval of Elonva, a new fertility drug. The injectible drug could make…
Submitted by Shelby D Burns Mon 02/01/2010 Beakers Merck announced in Europe the approval of Elonva, a new fertility drug. The injectible drug could make…
Submitted by Shelby D Burns Fri 02/11/2011 Tweet Sono The first babies born using a new technique developed at Oxford University to select the best…
Submitted by Shelby D Burns Tue 02/18/2014 Woman Menotropins are a mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) which are produced in the…
Submitted by Shelby D Burns Thu 03/20/2014 Angelo Gonzalez A year ago, a team of researchers at the University of Gothenburg performed the last of…
Submitted by Shelby D Burns Thu 07/24/2014 Clip art Letrozole results in higher birth rates for women with polycystic ovary syndrome (PCOS) than the current,…
Submitted by Shelby D Burns Tue 10/29/2013 Thinker Celmatix is a biotechnology company focused on helping physicians guide patients to treatments that maximize their personal…
Submitted by Shelby D Burns Thu 12/03/2009 Belly with steth Baby1 In the last few years, in vitro maturation (IVM) has made its debut and…
Submitted by Shelby D Burns Thu 03/20/2014 Angelo Gonzalez A year ago, a team of researchers at the University of Gothenburg performed the last of…
Submitted by Shelby D Burns Thu 07/24/2014 Clip art Letrozole results in higher birth rates for women with polycystic ovary syndrome (PCOS) than the current,…
Submitted by Shelby D Burns Tue 10/29/2013 thinker Celmatix is a biotechnology company focused on helping physicians guide patients to treatments that maximize their personal…